Controversias en tromboembolismo pulmonar masivo
Massive pulmonary embolism (PE) is associated with high mortality. There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria for defining a PE as massive is systemic arterial hypotension, which depends...
Guardado en:
Autores principales: | , , |
---|---|
Lenguaje: | Spanish / Castilian |
Publicado: |
Sociedad Médica de Santiago
2013
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000400010 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0034-98872013000400010 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0034-988720130004000102013-09-11Controversias en tromboembolismo pulmonar masivoMercado,MarceloAizman,AndrésAndresen,Max Pulmonary embolism Thrombectomy Thrombolytic therapy Massive pulmonary embolism (PE) is associated with high mortality. There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria for defining a PE as massive is systemic arterial hypotension, which depends on the extent of vascular obstruction and the previous cardiopulmonary status. Right ventricular dysfunction is an important pathogenic element to define the severity of patients and short term clinical prognosis. The recommended treatment is systemic thrombolysis, but in centers with experience and resources, radiological invasive therapies through catheters are useful alternatives that can be used as first choice tools in certain cases.info:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.141 n.4 20132013-04-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000400010es10.4067/S0034-98872013000400010 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
Spanish / Castilian |
topic |
Pulmonary embolism Thrombectomy Thrombolytic therapy |
spellingShingle |
Pulmonary embolism Thrombectomy Thrombolytic therapy Mercado,Marcelo Aizman,Andrés Andresen,Max Controversias en tromboembolismo pulmonar masivo |
description |
Massive pulmonary embolism (PE) is associated with high mortality. There is still a broad assortment of severity classifications for patients with PE, which affects the choice of therapies to use. The main clinical criteria for defining a PE as massive is systemic arterial hypotension, which depends on the extent of vascular obstruction and the previous cardiopulmonary status. Right ventricular dysfunction is an important pathogenic element to define the severity of patients and short term clinical prognosis. The recommended treatment is systemic thrombolysis, but in centers with experience and resources, radiological invasive therapies through catheters are useful alternatives that can be used as first choice tools in certain cases. |
author |
Mercado,Marcelo Aizman,Andrés Andresen,Max |
author_facet |
Mercado,Marcelo Aizman,Andrés Andresen,Max |
author_sort |
Mercado,Marcelo |
title |
Controversias en tromboembolismo pulmonar masivo |
title_short |
Controversias en tromboembolismo pulmonar masivo |
title_full |
Controversias en tromboembolismo pulmonar masivo |
title_fullStr |
Controversias en tromboembolismo pulmonar masivo |
title_full_unstemmed |
Controversias en tromboembolismo pulmonar masivo |
title_sort |
controversias en tromboembolismo pulmonar masivo |
publisher |
Sociedad Médica de Santiago |
publishDate |
2013 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872013000400010 |
work_keys_str_mv |
AT mercadomarcelo controversiasentromboembolismopulmonarmasivo AT aizmanandres controversiasentromboembolismopulmonarmasivo AT andresenmax controversiasentromboembolismopulmonarmasivo |
_version_ |
1718436684917374976 |